AN ACT relating to Medicaid prescription drugs.
     Create a new section of KRS Chapter 205 to define the terms "cabinet," "maximum allowable cost," and "multiple source drug"; permit a Medicaid managed care organization contracting with the cabinet to establish a maximum allowable cost for a drug if there are at least two or more bioequivalent or therapeutically equivalent multiple source noninnovator drugs available; establish criteria for determining the maximum allowable cost; require a Medicaid managed care organization to establish a process for a provider to appeal the maximum allowable cost.

     Mar 1-introduced in House
     Mar 5-to Health & Welfare (H)